Aflac Incorporated Reports Strong First Quarter Earnings and Growth for 2026

Financial Overview

Aflac Incorporated (NYSE: AFL) has announced its Q1 earnings for 2026, showcasing a remarkable performance that underscores its strategic focus and execution. The company reported total revenues of $4.3 billion, marking a 27.9% increase compared to the same quarter last year. Net earnings skyrocketed to $1.0 billion, translating to $1.98 per diluted share, a staggering rise from only $29 million or $0.05 per diluted share recorded a year prior.

Adjusted earnings stood at $901 million, just shy of the previous year's $906 million, reflecting a modest decrease of 0.6%. However, adjusted earnings per diluted share rose by 5.4%, reaching $1.75. Aflac's annualized return on shareholders' equity was reported at 13.7%, while an adjusted return, excluding foreign currency remeasurement, was noted at 16.4%.

The company returned a total of $1.3 billion to shareholders, consisting of $1.0 billion allocated for share repurchases and $315 million in dividends, emphasizing its commitment to returning value to investors.

Strategic Commentary

Daniel P. Amos, Aflac's Chairman and CEO, commented on the financial results: "Aflac delivered solid earnings for the quarter, reflecting our focus on creating long-term shareholder value through the successful execution of our strategy. Our innovative product initiatives, such as Anshin Palette (medical insurance), Miraito (cancer insurance), and Tsumitasu (life insurance) in Japan, have played a significant role in attracting new business. Additionally, we’ve expanded our offerings in the U.S. with group voluntary benefits, dental and vision, and group life and disability products."

Segment Performance

Aflac Japan reported a slight decline with net earned premiums of ¥247 billion, a decrease of 3.8% compared to the previous year. However, the launch of new products contributed to a 25.5% increase in new annualized premium sales, suggesting strong future growth potential.

In contrast, Aflac U.S. showed a positive trend with net earned premiums increasing by 3.5% to $1.6 billion and total adjusted revenues rising by 3.4%. This points to robust sales performance, particularly in group insurance products.

Investments and Future Outlook

During this quarter, Aflac has continued to strategically invest in its operations, maintaining a balanced approach to capital deployment to ensure profitable growth. The Board demonstrated its commitment to shareholders by increasing the first quarter dividend by 5.2%, projecting confidence in extending its legacy of 43 consecutive years of dividend increases.

In summary, Aflac Incorporated has showcased a robust first quarter performance in 2026, highlighting growth in revenues and net earnings, bolstered by strategic product initiatives. This solid groundwork sets an optimistic tone for the remainder of the fiscal year, illustrating Aflac's capability to navigate economic challenges while providing shareholder value and expanding its market presence.

Company Overview

Founded over seven decades ago, Aflac Incorporated is renowned for offering financial protection and peace of mind through its subsidiaries in the U.S. and Japan. Aflac is the primary provider of supplemental health insurance in the U.S. and leads the market for cancer and medical insurance in Japan. The company is recognized for its commitment to ethical business practices and has been acknowledged as one of the World’s Most Ethical Companies for the twentieth consecutive year in 2026. Aflac's strategic foresight, innovative product development, and dedication to stakeholder interests continue to solidify its position as a market leader in the insurance industry.